Valeant Disputes 'Erroneous' Enron-Like Allegations

Jon Moulton, founder at Better Capital, and Bloomberg's Sam Fazeli discuss the fallout from allegations of an Enron-like pricing scandal at Valeant Pharmaceuticals. They speak on "Bloomberg Surveillance." (Source: Bloomberg)

Infosys CEO Resigns After Criticism From Founders
36:04 - Infosys Ltd. Chief Executive Officer Vishal Sikka has stepped down following criticism from the company’s founder. Chief Operating Officer Pravin Rao will become interim CEO. Bloomberg's Caroline Hyde reports on "Bloomberg Technology." (Source: Bloomberg)
  • Essential's 360 Degree Approach to Smartphones
  • Why Industrial Metals May Be in a Bull Market
  • Who Moved the Most on Bloomberg's Billionaire Index 8/18